Loading…
Abingdon Health was awarded contracts worth approximately £4.8 million by a USA-based customer to develop and manufacture multiplex quantitative lateral flow assay systems, to be delivered over 27 months.
SYGNIS AG announced a partnership with Abingdon Health Ltd to provide full custom lateral flow assay development services, with SYGNIS as preferred colloidal gold supplier.